The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?

The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?

Locally advanced cervical cancer remains a significant therapeutic challenge, with high rates of recurrence and metastasis despite advances in chemoradiation. Immunotherapy, particularly immune checkpoint inhibitors targeting the PD-1/PD-L1 axis, has emerged as a promising strategy to enhance treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Fadila Kouhen, Adil El Ghanmi, Hanane Inghaoun, Hayat Miftah, Bouchra Ghazi, Abdallah Badou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
cervical cancer
chemoradiation
immunotherapy
immune checkpoint inhibitors
clinical trial
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1573576/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items